{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:45:28Z","timestamp":1782827128878,"version":"3.54.5"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00662","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T04:40:43Z","timestamp":1554266443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Gary L.","family":"Norman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette","family":"Vi\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wunsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Stinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Belen","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Aldegunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","article-title":"The immunobiology and pathophysiology of primary biliary cirrhosis","volume":"8","author":"Hirschfield","year":"2013","journal-title":"Annu Rev Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.clinre.2017.04.016","article-title":"Autoantibodies in antimitochondrial antibody negative primary biliary cholangitis","volume":"41","author":"Muratori","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","article-title":"Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease","volume":"7","author":"Milkiewicz","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front Immunol."},{"key":"B12","first-page":"495","article-title":"Detection of gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope","volume":"21","author":"Tartakovsky","year":"1995","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual i sotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1074\/mcp.M111.015529","article-title":"Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cell Proteomics."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2044-5040-4-11","article-title":"Kelch proteins: emerging roles in skeletal muscle development and diseases","volume":"4","author":"Gupta","year":"2014","journal-title":"Skeletal Muscle."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1479-7364-7-13","article-title":"Update on the Kelch-like (KLHL) gene family","volume":"7","author":"Dhanoa","year":"2013","journal-title":"Hum Genomics."},{"key":"B19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.4161\/cc.4.5.1678","article-title":"Mitochondrial hexokinases: guardians of the mitochondria","volume":"4","author":"Robey","year":"2005","journal-title":"Cell Cycle."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1038\/ctg.2017.43","article-title":"Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory-based study in Hong Kong between 2000 and 2015","volume":"8","author":"Cheung","year":"2017","journal-title":"Clin Translat Gastro"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","author":"Boonstra","year":"2012","journal-title":"J Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing Prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gast Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large- scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S355","DOI":"10.1016\/S0168-8278(17)31049-8","article-title":"The Novel Hexokinase (HK-1) antibodies are useful for diagnosis and associated with bad prognosis in primary biliary cholangitis","volume":"66","author":"Reig","year":"2017","journal-title":"J Hepatol"},{"key":"B26","first-page":"459","article-title":"Similar geographic prevalence of anti-hexokinase and anti-kelch like peptide antibodies in patients with primary biliary cholangitis-A large international multi-center study","volume-title":"Immunodeficiency, Infection and Autoimmune Diseases. Autoantigens, Autoantibodies, Autoimmunity","author":"Norman","year":"2017"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00662\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T04:40:45Z","timestamp":1554266445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00662\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2019.00662"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00662","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"article-number":"662"}}